Entero Healthcare Solutions Limited
Incorporated in 2018, Entero Healthcare Solutions Limited is a distributor of healthcare products in India
What Entero files
- Others68
- Investor Meet46
- Board Meeting18
- Important12
- Updates10
- JV/Acquisition8
Entero Healthcare announced a revised meeting link for its upcoming earnings call to discuss Q1FY27 financial results. All other call details and the schedule remain unchanged for investors and analysts.
Entero Healthcare Solutions Limited has informed the Exchange Annual Report for the financial year 2025-26 along with the Notice convening the 8th Annual General Meeting
Entero Healthcare Solutions will hold its 8th Annual General Meeting (AGM) virtually on August 19, 2026. Shareholders without registered emails are being notified about online access to the FY 2025-26 Annual Report.
Entero Healthcare submitted its Business Responsibility and Sustainability Report for FY2025-26. The company completed a merger of two subsidiaries, divested one, and struck off three non-operational entities. It also reduced Scope 1 GHG emissions to 744.18 Metric tonnes CO2e, demonstrating ongoing ESG commitment.
Entero Healthcare acquired a 51.5% stake in Anand Chemiceutics, a diagnostic and MedTech solutions provider. This expands Entero's presence in the high-growth MedTech market. The MedTech segment is projected to contribute over INR 1,000 Cr in annualised revenue next financial year.